Testing sputum for three microRNA biomarkers may help identify cancerous lung nodules
Oncology Nurse Advisor ,
Testing sputum for a panel of three microRNA (miRNA) biomarkers successfully distinguished early-stage lung cancers from…
Testing sputum for a panel of three microRNA (miRNA) biomarkers successfully distinguished early-stage lung cancers from…
Non-small cell lung cancer (NSCLC) is the most common cause of lung cancer deaths in the U.S., and resulted in a fatal outcome…
Among patients who had an unidentifiable lung nodule detected by a chest CT scan, testing sputum for a panel of three microRNA (m…
Among patients who had an unidentifiable lung nodule detected by a chest CT scan, testing sputum for a panel of three microRNA (m…